Log in

LON:HIKHikma Pharmaceuticals Price Target & Analyst Ratings

GBX 2,157
-17.00 (-0.78 %)
(As of 08/7/2020 05:18 AM ET)
Today's Range
Now: GBX 2,157
50-Day Range
MA: GBX 2,238.86
52-Week Range
Now: GBX 2,157
Volume684,944 shs
Average Volume822,138 shs
Market Capitalization£4.97 billion
P/E Ratio10.79
Dividend Yield2.25%

Analyst Ratings

Hikma Pharmaceuticals (LON:HIK) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Hikma Pharmaceuticals in the last 12 months. Their average twelve-month price target is GBX 2,478.57The high price target for HIK is GBX 2,860 and the low price target for HIK is GBX 2,200. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.502.502.382.13
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 2,478.57GBX 2,410GBX 2,378.33GBX 1,853.33

Hikma Pharmaceuticals (LON:HIK) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Hikma Pharmaceuticals (LON:HIK) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
7/30/2020Peel HuntBoost Price TargetBuyGBX 2,380 ➝ GBX 2,860
7/7/2020Morgan StanleyUpgradeOverweightGBX 2,200 ➝ GBX 2,600
4/28/2020BarclaysBoost Price TargetEqual WeightGBX 1,950 ➝ GBX 2,200
4/24/2020Goldman Sachs GroupDowngradeNeutralGBX 2,200 ➝ GBX 2,400
4/3/2020CitigroupBoost Price TargetBuyGBX 2,150 ➝ GBX 2,500
4/2/2020JPMorgan Chase & Co.UpgradeOverweightGBX 1,850 ➝ GBX 2,400
3/12/2020Jefferies Financial GroupBoost Price TargetBuyGBX 2,300 ➝ GBX 2,390
11/27/2019HSBCReiterated RatingReduce
3/13/2019Numis SecuritiesReiterated RatingHoldGBX 1,730
11/9/2017Stifel NicolausLower Price TargetHoldGBX 1,320 ➝ GBX 1,000
(Data available from 8/7/2018 forward)
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.